License to kill: Retinoic acid programs T cells for tissue residency.
Journal
The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R
Informations de publication
Date de publication:
01 05 2023
01 05 2023
Historique:
entrez:
10
3
2023
pubmed:
11
3
2023
medline:
15
3
2023
Statut:
ppublish
Résumé
In this issue of JEM, Qiu et al. (2023. J. Exp. Med. https://doi.org/10.1084/jem.20210923) show that retinoic acid signaling during priming in the mesenteric lymph node licenses CD8+ T cells to develop into small intestinal tissue-resident memory cells, a finding that provides key insights into tissue-specific vaccination strategies.
Identifiants
pubmed: 36897330
pii: 213931
doi: 10.1084/jem.20230161
pmc: PMC10035436
pii:
doi:
Substances chimiques
Tretinoin
5688UTC01R
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Comment
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : P01 AI132122
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI145815
Pays : United States
Commentaires et corrections
Type : CommentOn
Informations de copyright
© 2023 Heeg and Goldrath.
Références
Nat Rev Immunol. 2003 Nov;3(11):867-78
pubmed: 14668803
Mucosal Immunol. 2017 Nov;10(6):1518-1528
pubmed: 28327618
Annu Rev Immunol. 2019 Apr 26;37:521-546
pubmed: 30726153